Rifapentine
Back to searchMolecule Structure
Scientific Name
Rifapentine
Description of the Drug
Rifapentine is an antibiotic agent used in the treatment of pulmonary tuberculosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01201
http://www.drugbank.ca/drugs/DB01201
Brand Name(s)
Priftin
Company Owner(s)
Sanofi Aventis Us Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial DNA-directed RNA polymerase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2364672 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL41590 | |
DrugBank | DB01201 | |
PubChem: Thomson Pharma | 14865299 | 14889622 |
PubChem | 135403821 | |
LINCS | LSM-46028 | |
PDBe | RPT | |
BindingDB | 50248298 | |
EPA CompTox Dashboard | DTXSID8041115 | |
ChemicalBook | CB7482119 | |
rxnorm | RIFAPENTINE | PRIFTIN |
PubChem: Drugs of the Future | 12012718 | |
KEGG Ligand | C08059 | |
ChEBI | 45304 | |
ZINC | ZINC000169621228 |